Skip to content
Company Analysis

ProPhase Labs, Inc. PRPH

A comprehensive view of key metrics, scores, and financial health for ProPhase Labs, Inc.

Overview of ProPhase Labs, Inc.

PRPH PNK
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics Micro Cap
ProPhase Labs, Inc. (PRPH), is a Micro Cap company, in the Diagnostics & Research industry, last closed at $0.02, about 0.0% overvalued vs fair value, -99.6% 1Y return, ranked 1119/1145 in sector.
Metrics Rev Growth -35.8% ROE -271.5% Gross Margin 31.9%
USD 0.02
-14.50%
(Delayed)
• Vol 90d: 195.9%
Market Cap
$331,590
Enterprise Value
$9.43M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Weak
Valuation
Weak
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Weak
Valuation
Weak
Completeness: 100%
Confidence: 62%
Updated: Sep 12
Top Beats
No strong beats yet

Quick Facts

Website https://www.prophaselabs.com
HQ Garden City, NY
Employees 96
Fiscal year Dec 31

Next Events

Earnings Aug 21 Estimated

Fair Value Snapshot

Bear Base Bull
$-4
$-4
$-4
Current: $0.02

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$4.3M
-35.8%%
Gross Profit
$1.4M
1022.7%%
Operating Income (GAAP)
$-18.0M
53.3%%
EBITDA
$-11.4M
64.8%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
31.9%
Poor

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
1/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating ProPhase Labs, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
17
/100
Weak
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key risks

  • Below-Peer Gross Margins Gross margin quality lags peers (score 0.25). May indicate commodity-like product mix or distributor margin drag.
  • Weak FCF Generation FCF margin quality lags peers (score 0.11). Below-peer FCF conversion is a MedTech quality warning.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Weak
20
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing PRPH's balance between Growth (36.1%), Profitability (22.4%), and Safety (41.5%). Growth 36% Safety 42% Profitability 22%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

27th percentile vs peers
28
Key Signals
EPS Growth YoY 90.3% 85p Rev Growth YoY -35.8% 10p Revenue CAGR 3Y -67.2% 2p
Strengths
  • EPS Growth YoY in top 20% of peers (90.3%, 85th percentile)
  • Conservative leverage compared to industry peers
Risks
  • Rev Growth YoY in bottom 20% of peers (-35.8%)

Profitability

17th percentile vs peers
17
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

31th percentile vs peers
32
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for ProPhase Labs, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-4.00
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000